Caroline Phillips

Company: RedX Pharma

Job title: Chief Scientific Officer

Seminars:

Translating RXC007 preclinical antifibrotic efficacy to Ph2a PoC in IPF 9:30 am

Summarising RXC007 in vivo antifibrotic activity across preclinical rodent fibrosis models Presentation of RXC007 Ph2a anti-fibrotic signals in Ph2a IPF trial Exploratory circulating biomarkers in IPF and presentation of RXC007 changesRead more

day: Conference Day Two

Panel & Audience Discussion: What’s Next for Fibrosis? Understanding the Future Directions of the Antifibrotic Field 3:00 pm

This panel brings together experts from across various disease indications to explore the evolving scientific, translational, and clinical landscape of antifibrotic drug development to provide forward-looking perspective on where antifibrotic science is heading, which challenges are most urgent to overcome, and how industry and academia can collaborate more effectively to accelerate progress across diverse indication.…Read more

day: Conference Day Two